BASF Pharma Solutions announced a global price increase for excipients and selected active pharmaceutical ingredients (APIs) supplied by the company. The adjustment supports BASF’s commitment to maintaining a reliable supply of high-quality products across its portfolio amid rising global energy and raw material costs.A price increase of up to 20% will go into immediate effect, or as existing contracts allow. BASF Pharma Solutions will continue to monitor market conditions and communicate any future adjustments as needed.
BASF Pharma Solutions has announced a global price increase of up to 20 per cent on excipients and selected APIs, effective immediately or as contracts permit.
The move reflects rising energy and raw material costs, while supporting reliable supply of high-quality pharmaceutical inputs.
The company will continue to assess market conditions and update pricing as required.
Excipients are inactive ingredients that play a critical role in pharmaceutical formulations. APIs are the active components responsible for the therapeutic effect of medicines.
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (JP)
marketing@alchempro.com
